US Stock MarketDetailed Quotes

Pediatrix Medical (MD)

Watchlist
  • 21.975
  • +0.235+1.08%
Trading Apr 8 13:46 ET
1.83BMarket Cap11.33P/E (TTM)

Pediatrix Medical (MD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-4.92%1.91B
-1.71%493.77M
-3.58%492.88M
-7.03%468.84M
-7.42%458.36M
0.92%2.01B
1.19%502.36M
0.90%511.16M
0.74%504.3M
0.83%495.1M
Operating revenue
-5.40%1.9B
-2.05%491.54M
-4.14%489.91M
-7.57%465.63M
-7.92%454.56M
0.92%2.01B
0.99%501.81M
1.00%511.09M
0.76%503.76M
0.91%493.63M
Cost of revenue
-8.88%1.42B
-1.62%367.79M
-10.60%352.53M
-11.81%344.12M
-11.12%355.72M
-0.92%1.56B
-5.42%373.84M
-1.35%394.34M
1.31%390.18M
1.85%400.22M
Gross profit
8.66%493.7M
-1.98%125.98M
20.14%140.35M
9.30%124.73M
8.18%102.64M
7.78%454.34M
27.04%128.53M
9.29%116.82M
-1.16%114.12M
-3.24%94.88M
Operating expense
-2.97%262.62M
1.26%71.31M
3.06%66.34M
-6.62%61.03M
-9.32%63.94M
2.64%270.66M
13.36%70.43M
-3.37%64.38M
-2.39%65.36M
3.67%70.51M
Selling and administrative expenses
0.99%240.79M
3.35%65.68M
4.60%60.79M
-1.50%55.71M
-2.65%58.6M
4.79%238.44M
19.77%63.55M
1.25%58.12M
-2.50%56.57M
1.93%60.2M
-General and administrative expense
0.99%240.79M
3.35%65.68M
4.60%60.79M
-1.50%55.71M
-2.65%58.6M
4.79%238.44M
19.77%63.55M
1.25%58.12M
-2.50%56.57M
1.93%60.2M
Depreciation amortization depletion
-32.27%21.83M
-18.07%5.63M
-11.24%5.55M
-39.56%5.31M
-48.27%5.33M
-10.91%32.23M
-24.16%6.87M
-32.10%6.25M
-1.72%8.79M
15.13%10.31M
-Depreciation and amortization
-32.27%21.83M
-18.07%5.63M
-11.24%5.55M
-39.56%5.31M
-48.27%5.33M
-10.91%32.23M
-24.16%6.87M
-32.10%6.25M
-1.72%8.79M
15.13%10.31M
Operating profit
25.81%231.09M
-5.90%54.67M
41.11%74.01M
30.63%63.7M
58.81%38.71M
16.36%183.68M
48.82%58.1M
30.23%52.45M
0.55%48.76M
-18.87%24.37M
Net non-operating interest income expense
11.73%-35.97M
9.99%-8.74M
11.70%-8.94M
11.43%-9.13M
13.63%-9.15M
3.17%-40.74M
3.68%-9.71M
2.39%-10.13M
8.21%-10.31M
-2.01%-10.6M
Non-operating interest expense
-11.73%35.97M
-9.99%8.74M
-11.70%8.94M
-11.43%9.13M
-13.63%9.15M
-3.17%40.74M
-3.68%9.71M
-2.39%10.13M
-8.21%10.31M
2.01%10.6M
Other net income (expense)
108.72%21.31M
97.76%-338K
232.95%22.71M
100.19%398K
75.42%-1.46M
-48.83%-244.28M
91.02%-15.06M
-1,929.23%-17.09M
-12,380.11%-206.18M
-660.70%-5.95M
Gain on sale of security
230.01%19.05M
66.01%4.7M
440.22%5.88M
2,414.91%3.73M
135.32%4.74M
33.03%5.77M
26.23%2.83M
298.90%1.09M
-113.54%-161K
217.51%2.01M
Earnings from equity interest
54.99%3.63M
-8.07%843K
322.25%1.88M
8.84%505K
-21.62%406K
13.95%2.34M
91.44%917K
-32.68%445K
-5.31%464K
21.31%518K
Special income (charges)
99.46%-1.37M
68.74%-5.88M
180.31%14.95M
98.14%-3.83M
22.11%-6.61M
-48.00%-252.39M
88.97%-18.81M
---18.62M
---206.49M
---8.48M
-Less:Restructuring and merger&acquisition
-65.34%22.27M
-75.13%5.88M
-67.92%5.95M
-71.77%3.83M
-22.11%6.61M
2,795.90%64.26M
965.39%23.64M
--18.56M
--13.58M
--8.48M
-Less:Impairment of capital assets
--0
--0
--0
--0
----
20.31%178.44M
-102.43%-3.6M
--0
--182.03M
----
-Write off
--0
----
----
----
----
--0
----
----
----
----
-Gain on sale of business
315.55%20.91M
--0
35,533.90%20.91M
--0
----
---9.7M
--1.23M
---59K
---10.87M
----
Income before tax
313.57%216.43M
36.81%45.6M
247.84%87.78M
132.77%54.97M
259.02%28.09M
-109.56%-101.34M
124.00%33.33M
-18.15%25.24M
-530.66%-167.73M
-62.22%7.82M
Income tax
2,346.65%51.04M
318.26%11.91M
177.36%16.07M
206.84%15.71M
94.06%7.35M
-118.86%-2.27M
119.56%2.85M
-38.63%5.79M
-237.86%-14.7M
-41.76%3.79M
Net income
266.94%165.39M
10.51%33.68M
268.85%71.71M
125.66%39.26M
413.93%20.74M
-64.00%-99.07M
124.52%30.48M
-9.12%19.44M
-641.07%-153.03M
-71.60%4.04M
Net income continuous Operations
266.94%165.39M
10.51%33.68M
268.85%71.71M
125.66%39.26M
413.93%20.74M
-64.00%-99.07M
124.52%30.48M
-9.12%19.44M
-641.07%-153.03M
-71.60%4.04M
Net income discontinuous operations
----
----
----
----
----
--0
----
----
----
----
Minority interest income
0
Net income attributable to the parent company
266.94%165.39M
10.51%33.68M
268.85%71.71M
125.66%39.26M
413.93%20.74M
-64.00%-99.07M
124.52%30.48M
-9.12%19.44M
-641.07%-153.03M
-71.60%4.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
266.94%165.39M
10.51%33.68M
268.85%71.71M
125.66%39.26M
413.93%20.74M
-64.00%-99.07M
124.52%30.48M
-9.12%19.44M
-641.07%-153.03M
-71.60%4.04M
Basic earnings per share
265.55%1.97
15.50%0.41
269.57%0.85
125.00%0.46
400.00%0.25
-63.01%-1.19
124.00%0.355
-11.54%0.23
-641.18%-1.84
-70.59%0.05
Diluted earnings per share
263.03%1.94
12.68%0.4
265.22%0.84
125.00%0.46
380.00%0.24
-63.01%-1.19
123.66%0.355
-11.54%0.23
-641.18%-1.84
-70.59%0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -4.92%1.91B-1.71%493.77M-3.58%492.88M-7.03%468.84M-7.42%458.36M0.92%2.01B1.19%502.36M0.90%511.16M0.74%504.3M0.83%495.1M
Operating revenue -5.40%1.9B-2.05%491.54M-4.14%489.91M-7.57%465.63M-7.92%454.56M0.92%2.01B0.99%501.81M1.00%511.09M0.76%503.76M0.91%493.63M
Cost of revenue -8.88%1.42B-1.62%367.79M-10.60%352.53M-11.81%344.12M-11.12%355.72M-0.92%1.56B-5.42%373.84M-1.35%394.34M1.31%390.18M1.85%400.22M
Gross profit 8.66%493.7M-1.98%125.98M20.14%140.35M9.30%124.73M8.18%102.64M7.78%454.34M27.04%128.53M9.29%116.82M-1.16%114.12M-3.24%94.88M
Operating expense -2.97%262.62M1.26%71.31M3.06%66.34M-6.62%61.03M-9.32%63.94M2.64%270.66M13.36%70.43M-3.37%64.38M-2.39%65.36M3.67%70.51M
Selling and administrative expenses 0.99%240.79M3.35%65.68M4.60%60.79M-1.50%55.71M-2.65%58.6M4.79%238.44M19.77%63.55M1.25%58.12M-2.50%56.57M1.93%60.2M
-General and administrative expense 0.99%240.79M3.35%65.68M4.60%60.79M-1.50%55.71M-2.65%58.6M4.79%238.44M19.77%63.55M1.25%58.12M-2.50%56.57M1.93%60.2M
Depreciation amortization depletion -32.27%21.83M-18.07%5.63M-11.24%5.55M-39.56%5.31M-48.27%5.33M-10.91%32.23M-24.16%6.87M-32.10%6.25M-1.72%8.79M15.13%10.31M
-Depreciation and amortization -32.27%21.83M-18.07%5.63M-11.24%5.55M-39.56%5.31M-48.27%5.33M-10.91%32.23M-24.16%6.87M-32.10%6.25M-1.72%8.79M15.13%10.31M
Operating profit 25.81%231.09M-5.90%54.67M41.11%74.01M30.63%63.7M58.81%38.71M16.36%183.68M48.82%58.1M30.23%52.45M0.55%48.76M-18.87%24.37M
Net non-operating interest income expense 11.73%-35.97M9.99%-8.74M11.70%-8.94M11.43%-9.13M13.63%-9.15M3.17%-40.74M3.68%-9.71M2.39%-10.13M8.21%-10.31M-2.01%-10.6M
Non-operating interest expense -11.73%35.97M-9.99%8.74M-11.70%8.94M-11.43%9.13M-13.63%9.15M-3.17%40.74M-3.68%9.71M-2.39%10.13M-8.21%10.31M2.01%10.6M
Other net income (expense) 108.72%21.31M97.76%-338K232.95%22.71M100.19%398K75.42%-1.46M-48.83%-244.28M91.02%-15.06M-1,929.23%-17.09M-12,380.11%-206.18M-660.70%-5.95M
Gain on sale of security 230.01%19.05M66.01%4.7M440.22%5.88M2,414.91%3.73M135.32%4.74M33.03%5.77M26.23%2.83M298.90%1.09M-113.54%-161K217.51%2.01M
Earnings from equity interest 54.99%3.63M-8.07%843K322.25%1.88M8.84%505K-21.62%406K13.95%2.34M91.44%917K-32.68%445K-5.31%464K21.31%518K
Special income (charges) 99.46%-1.37M68.74%-5.88M180.31%14.95M98.14%-3.83M22.11%-6.61M-48.00%-252.39M88.97%-18.81M---18.62M---206.49M---8.48M
-Less:Restructuring and merger&acquisition -65.34%22.27M-75.13%5.88M-67.92%5.95M-71.77%3.83M-22.11%6.61M2,795.90%64.26M965.39%23.64M--18.56M--13.58M--8.48M
-Less:Impairment of capital assets --0--0--0--0----20.31%178.44M-102.43%-3.6M--0--182.03M----
-Write off --0------------------0----------------
-Gain on sale of business 315.55%20.91M--035,533.90%20.91M--0-------9.7M--1.23M---59K---10.87M----
Income before tax 313.57%216.43M36.81%45.6M247.84%87.78M132.77%54.97M259.02%28.09M-109.56%-101.34M124.00%33.33M-18.15%25.24M-530.66%-167.73M-62.22%7.82M
Income tax 2,346.65%51.04M318.26%11.91M177.36%16.07M206.84%15.71M94.06%7.35M-118.86%-2.27M119.56%2.85M-38.63%5.79M-237.86%-14.7M-41.76%3.79M
Net income 266.94%165.39M10.51%33.68M268.85%71.71M125.66%39.26M413.93%20.74M-64.00%-99.07M124.52%30.48M-9.12%19.44M-641.07%-153.03M-71.60%4.04M
Net income continuous Operations 266.94%165.39M10.51%33.68M268.85%71.71M125.66%39.26M413.93%20.74M-64.00%-99.07M124.52%30.48M-9.12%19.44M-641.07%-153.03M-71.60%4.04M
Net income discontinuous operations ----------------------0----------------
Minority interest income 0
Net income attributable to the parent company 266.94%165.39M10.51%33.68M268.85%71.71M125.66%39.26M413.93%20.74M-64.00%-99.07M124.52%30.48M-9.12%19.44M-641.07%-153.03M-71.60%4.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 266.94%165.39M10.51%33.68M268.85%71.71M125.66%39.26M413.93%20.74M-64.00%-99.07M124.52%30.48M-9.12%19.44M-641.07%-153.03M-71.60%4.04M
Basic earnings per share 265.55%1.9715.50%0.41269.57%0.85125.00%0.46400.00%0.25-63.01%-1.19124.00%0.355-11.54%0.23-641.18%-1.84-70.59%0.05
Diluted earnings per share 263.03%1.9412.68%0.4265.22%0.84125.00%0.46380.00%0.24-63.01%-1.19123.66%0.355-11.54%0.23-641.18%-1.84-70.59%0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More